6月4日，联合健康盘中上涨4.29%，报394.62美元/股，成交额5.1亿美元。
消息面上，美银证券将联合健康评级从"中性"上调至"买入"，目标价从420美元上调至450美元，较当前股价隐含约14%的上行空间。此外，Truist将目标价从395美元上调至440美元，奥本海默将目标价从405美元上调至420美元，机构密集看多。
美银分析师指出，此次上调主要依据医疗成本趋势持续改善，4月及5月医疗资源使用率数据向好，证明盈利改善具备持续性而非一季度偶发因素所致。同时，旗下UnitedHealthcare宣布年底前取消约三分之二针对18岁以下会员的预授权要求，有助于提升运营效率。市场对即将发布的二季度财报持积极预期。
联合健康集团是一家多元化健康服务公司，通过UnitedHealthcare提供医疗保健覆盖和福利服务，通过Optum提供信息和技术支持的健康服务。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.